FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198231363> ?p ?o ?g. }

• W3198231363 endingPage "23" @default.
• W3198231363 startingPage "22" @default.
• W3198231363 abstract "With interest, we read the article by Khan et al. about five adult patients with SARS-CoV-2 associated Guillain-Barré syndrome (SACAG) of whom one tested positive for virus RNA in the cerebrospinal fluid (CSF).1 Three patients were classified as acute, inflammatory, demyelinating polyneuropathy (AIDP) and one each as acute, motor, axonal neuropathy (AMAN) respectively acute, motor, and sensory, axonal neuropathy (AMSAN).1 It was concluded that “in a few cases where the symptoms of COVID-19 and GBS occur concurrently (corresponding to the viremic phase), a separate, para-infectious pathogenesis needs to be thought of”.1 The study is appealing but prompts comments and concerns. There is currently no evidence that SACAG is infectious. In a recent review of 300 patients with SACAG, of whom 68 underwent investigations for virus-RNA in the CSF, virus-RNA was detected only in a single patient.1 A second SACAG patient has been recently reported in whom CSF tested positive for the virus.2 Whether the presence of virus-RNA in these two cases represents false-positive results is unknown as no results of test-/retest-reliability were provided in either case.1, 2 Though it is conceivable that the low number of patients positive for virus-RNA in the CSF is due to the low number of SACAG patients undergoing investigative workup for virus-RNA in the CSF, there are several arguments that favor the immunogenic etiology of the condition. The first argument for immunogenic pathophysiology is that most SACAG cases respond favorably to immuno-suppressive or immune-modulating treatment. In the review elucidating 300 SACAG cases, 241 patients received intravenous immunoglobulins, 28 plasma exchange, and eight patients glucocorticoids [submitted]. Complete recovery from SACAG was achieved under these treatments in 42 patients, and incomplete recovery from SACAG in 163 patients at last follow-up respectively at discharge [submitted]. Merely 17 of the 300 patients died but it was not specified whether these patients deceased from COVID-19 or from SACAG. The second argument for an immunogenic pathophysiology is that virus-RNA has been detected in the CSF in only two patients so far reported.1, 2 Even if virus-RNA is present in the CSF of a SACAG patient, this does not exclude an immunogenic mechanism. The virus may be present transiently in all tissues, including the CSF, but perhaps does not attach to ACE-2 receptors if these are not expressed on specific surfaces. A third argument is that SARS-CoV-2 vaccinations markedly reduced the prevalence of SACAG. In a recent review of 300 SACAG patients, it has been shown the number of SACAG patients reported in the second half of 2020 (n = 192) declined by 61% in the first half of 2021 [submitted]. As SARS-CoV-2 vaccination had been introduced by December 2020, this finding suggests that vaccinations reduce the prevalence of SACAG patients. Vaccinations not only reduce the virus load but also evoke an immune reaction against the virus, which vehemently supports an immune mechanism. A fourth argument in favor of the immune hypothesis is that SACAG develops with a latency of up to 90 days after onset of clinical COVID-19 manifestations.3 As the virus can be found by nasopharyngeal swab tests only transiently, the long latency favors the immunogenic hypothesis. A fifth argument in favor of the immunogenic origin of SACAG is that cytokines are elevated in the CSF of SACAG patients.4 In particular, interleukin-8 has been found to be elevated in the CSF of SACAG patients.4 In addition to interleukin-8, interleukin-6 was elevated in the serum and CSF in the acute phase of SACAG patients.5 At the 4 months follow-up, only interleukin-8 had remained elevated in the serum.6 A further argument is that certain HLA alleles known to be associated with GBS, such as class-I (HLA-A33) and class-II alleles (DRB1*03:01 and DQB1*05:01), have also been detected in SACAG patients, further invoking an underlying immunogenic etiology.4 Another indication for an immune reaction is that CSF protein is usually elevated in the absence of pleocytosis.6 Overall, there are more arguments in favor of the immunogenic pathophysiology of SACAG than in favor of the infectious pathophysiology. The presence of virus-RNA in the CSF does not necessarily imply an infectious cause of SACAG. In light of the aforementioned points, this notion should be construed with due caution. The authors declare that there are no conflict of interests. Was in accordance if ethical guidelines. The study was approved by the institutional review board. Josef Finsterer: design, literature search, discussion, first draft, critical comments, final approval. Talal Almas: literature search, discussion, critical comments, final approval." @default.
• W3198231363 created "2021-09-13" @default.
• W3198231363 creator A5054213423 @default.
• W3198231363 creator A5060806470 @default.
• W3198231363 date "2021-09-08" @default.
• W3198231363 modified "2023-10-16" @default.
• W3198231363 title "Guillain‐Barré syndrome is immunogenic in SARS‐CoV‐2 infected" @default.
• W3198231363 cites W3089928797 @default.
• W3198231363 cites W3155941993 @default.
• W3198231363 cites W3158768882 @default.
• W3198231363 cites W3159737251 @default.
• W3198231363 cites W3160163127 @default.
• W3198231363 cites W3173729580 @default.
• W3198231363 doi "https://doi.org/10.1002/jmv.27314" @default.
• W3198231363 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34468997" @default.
• W3198231363 hasPublicationYear "2021" @default.
• W3198231363 type Work @default.
• W3198231363 sameAs 3198231363 @default.
• W3198231363 citedByCount "3" @default.
• W3198231363 countsByYear W31982313632022 @default.
• W3198231363 countsByYear W31982313632023 @default.
• W3198231363 crossrefType "journal-article" @default.
• W3198231363 hasAuthorship W3198231363A5054213423 @default.
• W3198231363 hasAuthorship W3198231363A5060806470 @default.
• W3198231363 hasBestOaLocation W31982313631 @default.
• W3198231363 hasConcept C10162356 @default.
• W3198231363 hasConcept C104317684 @default.
• W3198231363 hasConcept C137627325 @default.
• W3198231363 hasConcept C142724271 @default.
• W3198231363 hasConcept C159047783 @default.
• W3198231363 hasConcept C203014093 @default.
• W3198231363 hasConcept C2522874641 @default.
• W3198231363 hasConcept C2778691916 @default.
• W3198231363 hasConcept C2779174946 @default.
• W3198231363 hasConcept C2781200757 @default.
• W3198231363 hasConcept C55493867 @default.
• W3198231363 hasConcept C67705224 @default.
• W3198231363 hasConcept C71924100 @default.
• W3198231363 hasConcept C86803240 @default.
• W3198231363 hasConceptScore W3198231363C10162356 @default.
• W3198231363 hasConceptScore W3198231363C104317684 @default.
• W3198231363 hasConceptScore W3198231363C137627325 @default.
• W3198231363 hasConceptScore W3198231363C142724271 @default.
• W3198231363 hasConceptScore W3198231363C159047783 @default.
• W3198231363 hasConceptScore W3198231363C203014093 @default.
• W3198231363 hasConceptScore W3198231363C2522874641 @default.
• W3198231363 hasConceptScore W3198231363C2778691916 @default.
• W3198231363 hasConceptScore W3198231363C2779174946 @default.
• W3198231363 hasConceptScore W3198231363C2781200757 @default.
• W3198231363 hasConceptScore W3198231363C55493867 @default.
• W3198231363 hasConceptScore W3198231363C67705224 @default.
• W3198231363 hasConceptScore W3198231363C71924100 @default.
• W3198231363 hasConceptScore W3198231363C86803240 @default.
• W3198231363 hasIssue "1" @default.
• W3198231363 hasLocation W31982313631 @default.
• W3198231363 hasLocation W31982313632 @default.
• W3198231363 hasLocation W31982313633 @default.
• W3198231363 hasLocation W31982313634 @default.
• W3198231363 hasOpenAccess W3198231363 @default.
• W3198231363 hasPrimaryLocation W31982313631 @default.
• W3198231363 hasRelatedWork W2022308776 @default.
• W3198231363 hasRelatedWork W2029273218 @default.
• W3198231363 hasRelatedWork W2057885640 @default.
• W3198231363 hasRelatedWork W2089686585 @default.
• W3198231363 hasRelatedWork W2111318940 @default.
• W3198231363 hasRelatedWork W2142935324 @default.
• W3198231363 hasRelatedWork W2255974537 @default.
• W3198231363 hasRelatedWork W2412177315 @default.
• W3198231363 hasRelatedWork W2991196271 @default.
• W3198231363 hasRelatedWork W3092892646 @default.
• W3198231363 hasVolume "94" @default.
• W3198231363 isParatext "false" @default.
• W3198231363 isRetracted "false" @default.
• W3198231363 magId "3198231363" @default.
• W3198231363 workType "article" @default.